# Picankibart in Palmoplantar Pustulosis

> **NCT07552454** · NA · RECRUITING · sponsor: **Xijing Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Palmoplantar Pustulosis

## Interventions

- **DRUG:** Picankibart

## Key facts

- **NCT ID:** NCT07552454
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-15
- **Primary completion:** 2027-10-15
- **Final completion:** 2027-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07552454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07552454, "Picankibart in Palmoplantar Pustulosis". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07552454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*